Harrow, Inc. (HROW)
30.86
+1.04
(+3.47%)
USD |
NASDAQ |
May 14, 16:00
30.86
0.00 (0.00%)
After-Hours: 20:00
Harrow Cash from Investing (Quarterly) : -18.20M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -3.916B |
| Esperion Therapeutics, Inc. | -0.189M |
| Theravance Biopharma, Inc. | 52.59M |
| Xeris Biopharma Holdings, Inc. | -0.325M |
| Aquestive Therapeutics, Inc. | -0.085M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.992M |
| Cash from Financing (Quarterly) | 48.91M |
| Free Cash Flow | 14.11M |
| Free Cash Flow Per Share (Quarterly) | -0.247 |
| Free Cash Flow to Equity (Quarterly) | -57.89M |
| Free Cash Flow to Firm (Quarterly) | -3.693M |
| Free Cash Flow Yield | 1.20% |